<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73898">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01947543</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol no: 2012-11</org_study_id>
    <nct_id>NCT01947543</nct_id>
  </id_info>
  <brief_title>Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study</brief_title>
  <official_title>Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Orebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Orebro</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to screen a well characterized patient population with ventricular
      tachycardia  of unknown origin and treated with an implantable cardioverter-defibrillator
      (ICD) for mutations in the calmodulin genes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with ventricular tachycardia  of unknown origin and treated with an implantable
      cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients
      with results showing mutations in the calmodulin genes, family members (parents, siblings
      and children) will also be asked to participate in the study. For under age patients and
      relatives who agree to participate, informed consent will also be taken from their
      custodian.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Mutations in the calmodulin genes</measure>
    <time_frame>1 month.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Ventricular tachycardia</arm_group_label>
    <description>Patients with ventricular tachycardia of unknown origin treated with an ICD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Family members</arm_group_label>
    <description>Family members (parents, siblings and children) for patients with results showing mutations in the calmodulin genes.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ventricular tachycardia of unknown origin and treated with an ICD
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ventricular tachycardia of unknown origin that have been treated with
             an ICD

          -  Signed and dated informed consent

        Exclusion Criteria:

        - Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ole Fröbert, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Örebro University Hospital, Örebro, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ole Fröbert</last_name>
    <phone>+46 19 602 10 00</phone>
    <email>ole.frobert@orebroll.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology, Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Linde</last_name>
      <phone>+46 19 602 10 00</phone>
    </contact>
    <investigator>
      <last_name>Peter Linde</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ole Fröbert, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 23, 2013</lastchanged_date>
  <firstreceived_date>August 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Orebro</investigator_affiliation>
    <investigator_full_name>Ole Frobert</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
